Status:
UNKNOWN
Testing and Epidemiology of Delta Hepatitis
Lead Sponsor:
Asian Pacific Liver Center at Coalition of Inclusive Medicine
Collaborating Sponsors:
Gilead Sciences
Conditions:
Chronic Hepatitis D Infection With Hepatitis B
Eligibility:
All Genders
18+ years
Brief Summary
Study is to 1. Understand the pattern of hepatitis delta screening among medical providers for Asian patients with chronic hepatitis B 2. Determine the proportion of Asian hepatitis B patients who ha...
Detailed Description
Chronic hepatitis B (CHB) affects more than 257 million people world-wide with two-thirds of CHB infected people living in Asia and Sub-Saharan Africa. Although the overall prevalence of CHB is high i...
Eligibility Criteria
Inclusion
- 18 years and older chronic hepatitis B patients
Exclusion
- 17 years and younger chronic hepatitis B patients
Key Trial Info
Start Date :
January 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05181956
Start Date
January 3 2022
End Date
March 31 2023
Last Update
January 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asian Pacific Liver Center
Los Angeles, California, United States, 90020